Exactech, Inc.  

(Public, NASDAQ:EXAC)   Watch this stock  
Find more results for Chip Miller
23.16
-0.24 (-1.03%)
Real-time:   1:37PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 22.97 - 23.30
52 week 17.80 - 25.14
Open 23.23
Vol / Avg. 18,928.00/25,722.00
Mkt cap 314.60M
P/E 20.70
Div/yield     -
EPS 1.12
Shares 13.58M
Beta 1.23
Inst. own 60%
Jul 21, 2014
Q2 2014 Exactech Earnings Release (Estimated) Add to calendar
Apr 22, 2014
Q1 2014 Exactech Earnings Conference Call
Apr 21, 2014
Q1 2014 Exactech Earnings Release
Mar 11, 2014
Exactech at Canaccord Genuity's Musculoskeletal Conference
Feb 20, 2014
Q4 2013 Exactech Earnings Conference Call
Feb 19, 2014
Q4 2013 Exactech Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 6.64% 6.48%
Operating margin 10.45% 10.09%
EBITD margin - 17.51%
Return on average assets 6.51% 6.06%
Return on average equity 8.62% 8.46%
Employees 608 -
CDP Score - -

Address

2320 NW 66TH COURT
GAINESVILLE, FL 32653
United States - Map
+1-352-3771140 (Phone)
+1-352-3782617 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Exactech, Inc. develops, manufactures and sells orthopedic implant devices, related surgical instruments and biological material and services to make patients more mobile. The Company offers various joint replacement systems, including knee, shoulder, and hip implant systems; and biologic allograft services and bone cement materials used in orthopedic surgery for the repair or replacement of joints.

Officers and directors

William Petty M.D. Executive Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
David W. Petty Chief Executive Officer, Director
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joel C. Phillips CPA Chief Financial Officer, Treasurer
Age: 45
Bio & Compensation  - Reuters
Gary J. Miller Ph.D. Executive Vice President - Research and Development
Age: 65
Bio & Compensation  - Reuters
Bruce E Thompson Senior Vice President, General Manager - Biologics and Spine Division
Age: 55
Bio & Compensation  - Reuters
Donna M. Edwards Vice President - Legal
Age: 40
Bio & Compensation  - Reuters
Betty A. Petty Vice President - Administration, Corporate Secretary
Age: 70
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Albert H Burstein Ph.D. Director
Age: 75
Bio & Compensation  - Reuters
James G. Binch Independent Director
Age: 65
Bio & Compensation  - Reuters
William B. Locander Ph.D. Independent Director
Age: 69
Bio & Compensation  - Reuters